Railtel To Bajaj Auto: CK Narayan Identifies Top Bets
Momentum is characterised by short bursts, rather than sustained activity and investors should dive in and take advantage of these brief bursts in order to capitalise on opportunities, according to CK Narayan, founder of NeoTrader & Growth Avenues.
The current market exhibits significant momentum, he said in an interview with NDTV Profit.
These are Narayan's top picks for auto and railways stocks:
Auto Stocks
Two-wheeler stocks such as Bajaj Auto Ltd., Hero MotoCorp Ltd., Eicher Motors Ltd., and TVS Motor Co. are currently experiencing a remarkable upswing. The attained stock prices are not alarming investors, and the momentum in these stocks is expected to endure.
There is considerable anticipation surrounding Tata Motors Ltd., particularly from the commercial vehicle standpoint, according to Narayan. If one were to focus on the commercial vehicle sector, the Tata Group company would be a promising bet, he said.
"I would focus more on the two-wheeler stocks than the four-wheelers."
Railways Stocks
The surge in share prices of Railtel Corp. of India is due to the technolog mix and widespread takers, according to Narayan.
While wagon manufacturers experienced a significant upward movement, there seems to be a desire for a breather in their momentum.
The remaining railway stocks have also been exhibiting a more gradual upward trend. Narayan suggests the strategy of buying at dips for wagon manufacturers.
There appears to be ample potential for further growth in other railway stocks, Narayan said. The railway sector is currently in a sweet spot, benefiting from a tremendous tailwind for more than a year, he said.
This favourable trend shows no signs of dissipating any time soon, Narayan said.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.